Keitaro Yamanouchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keitaro Yamanouchi has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
Masugi Nishihara
Laboratory of Veterinary Physiology, Graduate School of Agricultural and Life Sciences The University of Tokyo Tokyo Japan
29 shared publicationsTakashi Matsuwaki
Laboratory of Veterinary Physiology, Graduate School of Agricultural and Life Sciences The University of Tokyo Tokyo Japan
18 shared publicationsKatsuyuki Nakamura
Department of Chemistry and Biomolecular Science, Biomolecular Science Course, Faculty of Engineering Gifu University Gifu Japan
15 shared publicationsHidetoshi Sugihara
Laboratory of Veterinary Physiology, Graduate School of Agricultural and Life Sciences The University of Tokyo Tokyo Japan
10 shared publicationsShin-Ichi Nakano
Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
8 shared publicationsNaomi Teramoto
Laboratory of Veterinary Physiology, Graduate School of Agricultural and Life Sciences The University of Tokyo Tokyo Japan
7 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Wiley in Acta Physiologica
- Vol. 242 (9)
Immune‐Induced Fever and Psychogenic Hyperthermia Can Occur Independently of Uncoupling Protein 1‐Mediated Brown Adipose Tissue Thermogenesis
Aim: Brown adipose tissue thermogenesis is widely considered an important effector mechanism in fever and emotionally induced hyperthermia (psychogenic fever), and increases in interscapular temperature are commonly interpreted as evidence of brown adipose tissue activation. Yet direct evidence for this interpretation remains limited and conflicting. Here, we tested these assumptions using complementary genetic and surgical approaches in rats. Methods: We generated uncoupling protein 1 knockout rats, in which canonical brown adipose tissue thermogenesis is abolished, and examined body temperature responses to systemic inflammation induced by lipopolysaccharide and to emotional stressors, including restraint and cage exchange. In separate experiments, interscapular brown adipose tissue was surgically removed in wild‐type rats. Results: Despite profound impairment of cold‐ and β ₃ ‐adrenergic‐induced thermogenesis, uncoupling protein 1 deletion did not affect lipopolysaccharide‐ or stress‐induced increases in core or interscapular temperature. Likewise, removal of interscapular brown adipose tissue did not alter the interscapular temperature response. Thus, increases in interscapular temperature occurred in the absence of both uncoupling protein 1 and interscapular brown adipose tissue. Consistent with these findings, immune challenge and emotional stress induced little or no change in thermogenic gene expression and had minimal effects on tissue mass, in contrast to robust activation by β ₃ ‐adrenergic stimulation. Conclusion: Fever and psychogenic hyperthermia in rats do not require uncoupling protein 1‐mediated brown adipose tissue thermogenesis. Furthermore, increases in interscapular temperature are not necessarily indicative of brown adipose tissue thermogenesis, challenging a widely held interpretation of these phenomena.
- 25 August 2026
- Published by Wiley in Acta Physiologica
- Vol. 242 (9)
Open AccessImmune‐Induced Fever and Psychogenic Hyperthermia Can Occur Independently of Uncoupling Protein 1‐Mediated Brown Adipose Tissue Thermogenesis
Aim: Brown adipose tissue thermogenesis is widely considered an important effector mechanism in fever and emotionally induced hyperthermia (psychogenic fever), and increases in interscapular temperature are commonly interpreted as evidence of brown adipose tissue activation. Yet direct evidence for this interpretation remains limited and conflicting. Here, we tested these assumptions using complementary genetic and surgical approaches in rats. Methods: We generated uncoupling protein 1 knockout rats, in which canonical brown adipose tissue thermogenesis is abolished, and examined body temperature responses to systemic inflammation induced by lipopolysaccharide and to emotional stressors, including restraint and cage exchange. In separate experiments, interscapular brown adipose tissue was surgically removed in wild‐type rats. Results: Despite profound impairment of cold‐ and β ₃ ‐adrenergic‐induced thermogenesis, uncoupling protein 1 deletion did not affect lipopolysaccharide‐ or stress‐induced increases in core or interscapular temperature. Likewise, removal of interscapular brown adipose tissue did not alter the interscapular temperature response. Thus, increases in interscapular temperature occurred in the absence of both uncoupling protein 1 and interscapular brown adipose tissue. Consistent with these findings, immune challenge and emotional stress induced little or no change in thermogenic gene expression and had minimal effects on tissue mass, in contrast to robust activation by β ₃ ‐adrenergic stimulation. Conclusion: Fever and psychogenic hyperthermia in rats do not require uncoupling protein 1‐mediated brown adipose tissue thermogenesis. Furthermore, increases in interscapular temperature are not necessarily indicative of brown adipose tissue thermogenesis, challenging a widely held interpretation of these phenomena.
- Open Access
Pathology-targeted EP4 agonism resolves fibrosis and restores regeneration in a rat model of adolescent Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) presents a critical therapeutic gap in adolescent patients, where extensive fibro-fatty muscle replacement and depletion of the regenerative niche render existing interventions insufficient. Prostaglandin E2 signaling through the EP4 receptor stimulates bone and muscle regeneration and repair, but systemic off-target effects have limited the clinical translation of EP4 agonism in diseases such as DMD. We therefore evaluated irodanoprost (IROD), a bone-targeted prodrug of an EP4-selective agonist, in a DMD rat model, comparing early- and late-intervention cohorts. In adolescent rats, 8 weeks of treatment reduced body weight deficit by 41.4% and restored hindlimb muscle mass and maximum tetanic force to wild-type levels. IROD dose-dependently inhibited fibro-adipogenic progenitor differentiation into α-SMA⁺ myofibroblasts, facilitating active resolution of established fibrosis below pre-treatment baseline. This was accompanied by re-activation of a synchronized regenerative program marked by clustered eMHC⁺ fibers, restoring the total myofiber pool to wild-type levels. A strong linear correlation between intramuscular fat reduction and fibrosis resolution suggests that MRI-based fat imaging may serve as a non-invasive surrogate for monitoring anti-fibrotic efficacy. The efficacy of IROD is likely aided by the fact that while it selectively distributes to bone in healthy animals, we observed markedly enhanced accumulation of the drug in dystrophic muscle. These findings establish IROD as a pathology-targeted approach capable of resolving the fibro-fatty niche and restoring regenerative capacity in advanced DMD. Summary: Pathology-targeted EP4 agonism resolves established fibrosis and restores myofiber regeneration in a rat model of adolescent Duchenne dystrophy. Graphic
Open AccessPathology-targeted EP4 agonism resolves fibrosis and restores regeneration in a rat model of adolescent Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) presents a critical therapeutic gap in adolescent patients, where extensive fibro-fatty muscle replacement and depletion of the regenerative niche render existing interventions insufficient. Prostaglandin E2 signaling through the EP4 receptor stimulates bone and muscle regeneration and repair, but systemic off-target effects have limited the clinical translation of EP4 agonism in diseases such as DMD. We therefore evaluated irodanoprost (IROD), a bone-targeted prodrug of an EP4-selective agonist, in a DMD rat model, comparing early- and late-intervention cohorts. In adolescent rats, 8 weeks of treatment reduced body weight deficit by 41.4% and restored hindlimb muscle mass and maximum tetanic force to wild-type levels. IROD dose-dependently inhibited fibro-adipogenic progenitor differentiation into α-SMA⁺ myofibroblasts, facilitating active resolution of established fibrosis below pre-treatment baseline. This was accompanied by re-activation of a synchronized regenerative program marked by clustered eMHC⁺ fibers, restoring the total myofiber pool to wild-type levels. A strong linear correlation between intramuscular fat reduction and fibrosis resolution suggests that MRI-based fat imaging may serve as a non-invasive surrogate for monitoring anti-fibrotic efficacy. The efficacy of IROD is likely aided by the fact that while it selectively distributes to bone in healthy animals, we observed markedly enhanced accumulation of the drug in dystrophic muscle. These findings establish IROD as a pathology-targeted approach capable of resolving the fibro-fatty niche and restoring regenerative capacity in advanced DMD. Summary: Pathology-targeted EP4 agonism resolves established fibrosis and restores myofiber regeneration in a rat model of adolescent Duchenne dystrophy. Graphic
- Open Access
- 23 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71567
Senescent‐Like Myofibers Contribute to Anti‐Regenerative Cytokine Signaling in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a genetic muscular disease characterized by progressive muscle degeneration. p16 is expressed in skeletal muscles and induces cellular senescence in a rat model of DMD, whereas its ablation enhances muscle regeneration. However, the mechanism underlying this phenomenon remains unclear. This study aimed to elucidate the mechanism for p16‐induced DMD exacerbation. RNA‐seq analysis revealed p16‐dependent upregulation of cytokine gene expression in DMD rat skeletal muscles, which also altered the systemic blood cytokine profile. Furthermore, the effect of an altered humoral environment on muscle regeneration was assessed using the transplanted extensor digitorum longus muscle. Regeneration of grafted muscles from wild‐type rats was suppressed in DMD rats but was significantly improved by p16 ablation. Notably, p16 was expressed in the myofibers of DMD rats, and enzymatically isolated myofibers from DMD rats also showed p16‐dependent cytokine expression. Thus, cytokines secreted by senescent‐like myofibers mediate the anti‐regenerative niche in DMD rats, uncovering a novel mechanism for disease progression and potential therapeutic targets.
- 23 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71567
Open AccessSenescent‐Like Myofibers Contribute to Anti‐Regenerative Cytokine Signaling in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a genetic muscular disease characterized by progressive muscle degeneration. p16 is expressed in skeletal muscles and induces cellular senescence in a rat model of DMD, whereas its ablation enhances muscle regeneration. However, the mechanism underlying this phenomenon remains unclear. This study aimed to elucidate the mechanism for p16‐induced DMD exacerbation. RNA‐seq analysis revealed p16‐dependent upregulation of cytokine gene expression in DMD rat skeletal muscles, which also altered the systemic blood cytokine profile. Furthermore, the effect of an altered humoral environment on muscle regeneration was assessed using the transplanted extensor digitorum longus muscle. Regeneration of grafted muscles from wild‐type rats was suppressed in DMD rats but was significantly improved by p16 ablation. Notably, p16 was expressed in the myofibers of DMD rats, and enzymatically isolated myofibers from DMD rats also showed p16‐dependent cytokine expression. Thus, cytokines secreted by senescent‐like myofibers mediate the anti‐regenerative niche in DMD rats, uncovering a novel mechanism for disease progression and potential therapeutic targets.
- Open Access
- 1 January 2025
- Published by Wiley in Animal Science Journal
- Vol. 96 (1) , e70097
Possible Involvement of CSPG4 in Promoting Endothelial Cell Migration and Contributing to Angiogenesis during Skeletal Muscle Regeneration and Development in the Rat
Skeletal muscle regeneration is a complex process that requires coordinated interactions between myogenic and vascular cells. Chondroitin sulfate proteoglycan 4 (CSPG4), a cell surface proteoglycan, had been shown to be expressed around immature myofibers in patients with Duchenne muscular dystrophy, suggesting its role in muscle regeneration. In the present study, we found that CSPG4 is transiently expressed by regenerating myofibers upon muscle injury in the rat. We generated the CSPG4 knockout (KO) rats to investigate its role in muscle regeneration. In CSPG4 KO rats, skeletal muscle development was perturbed with impaired angiogenesis. When muscle regeneration was induced, CSPG4 KO rats showed a reduced number of CD31‐positive cells at the regenerating site. These results suggest the role of CSPG4 in angiogenesis during muscle regeneration and development. In vitro, coculture of CSPG4‐expressing mesenchymal progenitor cells (MPC) promoted vascular endothelial cell migration, whereas the KO of CSPG4 in MPC abrogated the upregulation of endothelial cell migration. Our findings identify CSPG4 as a key regulator of vascular endothelial cell recruitment during muscle vascular remodeling and highlight its potential as a therapeutic target for Duchenne muscular dystrophy, which is characterized by impaired angiogenesis.
- 1 January 2025
- Published by Wiley in Animal Science Journal
- Vol. 96 (1) , e70097
Open AccessPossible Involvement of CSPG4 in Promoting Endothelial Cell Migration and Contributing to Angiogenesis during Skeletal Muscle Regeneration and Development in the Rat
Skeletal muscle regeneration is a complex process that requires coordinated interactions between myogenic and vascular cells. Chondroitin sulfate proteoglycan 4 (CSPG4), a cell surface proteoglycan, had been shown to be expressed around immature myofibers in patients with Duchenne muscular dystrophy, suggesting its role in muscle regeneration. In the present study, we found that CSPG4 is transiently expressed by regenerating myofibers upon muscle injury in the rat. We generated the CSPG4 knockout (KO) rats to investigate its role in muscle regeneration. In CSPG4 KO rats, skeletal muscle development was perturbed with impaired angiogenesis. When muscle regeneration was induced, CSPG4 KO rats showed a reduced number of CD31‐positive cells at the regenerating site. These results suggest the role of CSPG4 in angiogenesis during muscle regeneration and development. In vitro, coculture of CSPG4‐expressing mesenchymal progenitor cells (MPC) promoted vascular endothelial cell migration, whereas the KO of CSPG4 in MPC abrogated the upregulation of endothelial cell migration. Our findings identify CSPG4 as a key regulator of vascular endothelial cell recruitment during muscle vascular remodeling and highlight its potential as a therapeutic target for Duchenne muscular dystrophy, which is characterized by impaired angiogenesis.
- Open Access
- 9 October 2024
- Published by Elsevier in Neuroscience
- Vol. 560, 326-333
Hypercorticosteronemia induces hyperphagia and obesity in human growth hormone transgenic rats
- 9 October 2024
- Published by Elsevier in Neuroscience
- Vol. 560, 326-333
Open AccessHypercorticosteronemia induces hyperphagia and obesity in human growth hormone transgenic rats
- Open Access
- 1 January 2024
- Published by Japanese Society of Animal Reproduction in Journal of Reproduction and Development
- Vol. 70 (2) , 55-64
Identification and characterization of dystrophin-locus-derived testis-specific protein: A testis-specific gene within the intronic region of the rat dystrophin gene
The mammalian X chromosome exhibits enrichment in genes associated with germ cell development. Previously, we generated a rat model of Becker muscular dystrophy (BMD) characterized by an in-frame mutation in the dystrophin gene, situated on the X chromosome and responsible for encoding a protein crucial for muscle integrity. Male BMD rats are infertile owing to the absence of normal spermatids in the epididymis. Within the seminiferous tubules of BMD rats, elongated spermatids displayed abnormal morphology. To elucidate the cause of infertility, we identified a putative gene containing an open reading frame situated in the intronic region between exons 6 and 7 of the dystrophin gene, specifically deleted in male BMD rats. This identified gene, along with its encoded protein, exhibited specific detection within the testes, exclusively localized in round to elongated spermatids during spermiogenesis. Consequently, we designated the encoded protein as dystrophin-locus-derived testis-specific protein (DTSP). Given the absence of DTSP in the testes of BMD rats, we hypothesized that the loss of DTSP contributes to the infertility observed in male BMD rats.
- 1 January 2024
- Published by Japanese Society of Animal Reproduction in Journal of Reproduction and Development
- Vol. 70 (2) , 55-64
Open AccessIdentification and characterization of dystrophin-locus-derived testis-specific protein: A testis-specific gene within the intronic region of the rat dystrophin gene
The mammalian X chromosome exhibits enrichment in genes associated with germ cell development. Previously, we generated a rat model of Becker muscular dystrophy (BMD) characterized by an in-frame mutation in the dystrophin gene, situated on the X chromosome and responsible for encoding a protein crucial for muscle integrity. Male BMD rats are infertile owing to the absence of normal spermatids in the epididymis. Within the seminiferous tubules of BMD rats, elongated spermatids displayed abnormal morphology. To elucidate the cause of infertility, we identified a putative gene containing an open reading frame situated in the intronic region between exons 6 and 7 of the dystrophin gene, specifically deleted in male BMD rats. This identified gene, along with its encoded protein, exhibited specific detection within the testes, exclusively localized in round to elongated spermatids during spermiogenesis. Consequently, we designated the encoded protein as dystrophin-locus-derived testis-specific protein (DTSP). Given the absence of DTSP in the testes of BMD rats, we hypothesized that the loss of DTSP contributes to the infertility observed in male BMD rats.
- 6 July 2023
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 576, 112008
Characterization of pathogenic factors for premenstrual dysphoric disorder using machine learning algorithms in rats
- 6 July 2023
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 576, 112008
Characterization of pathogenic factors for premenstrual dysphoric disorder using machine learning algorithms in rats
- 31 March 2023
- Published by Springer Nature
- Vol. 2640, 277-285
In Vivo Modeling of Skeletal Muscle Diseases Using the CRISPR/Cas9 System in Rats
The CRISPR/Cas9 system is a powerful gene editing tool that can be used to modify a target gene in almost all species. It unlocks the possibility of generating knockout or knock-in genes in laboratory animals other than mice. The Dystrophin gene is implicated in human Duchenne muscular dystrophy; however, Dystrophin gene mutant mice do not show severe muscle degenerating phenotypes when compared to humans. On the other hand, Dystrophin gene mutant rats made with the CRISPR/Cas9 system show more severe phenotypes than those seen in mice. The phenotypes seen in dystrophin mutant rats are more representative of the features of human DMD. This implies that rats are better models of human skeletal muscle diseases than mice. In this chapter, we present a detailed protocol for the generation of gene-modified rats by microinjection into embryos using the CRISPR/Cas9 system. Key words CRISPR/Cas9 Genome editing Gene-modified rats Duchenne muscular dystrophy
- 31 March 2023
- Published by Springer Nature
- Vol. 2640, 277-285
In Vivo Modeling of Skeletal Muscle Diseases Using the CRISPR/Cas9 System in Rats
The CRISPR/Cas9 system is a powerful gene editing tool that can be used to modify a target gene in almost all species. It unlocks the possibility of generating knockout or knock-in genes in laboratory animals other than mice. The Dystrophin gene is implicated in human Duchenne muscular dystrophy; however, Dystrophin gene mutant mice do not show severe muscle degenerating phenotypes when compared to humans. On the other hand, Dystrophin gene mutant rats made with the CRISPR/Cas9 system show more severe phenotypes than those seen in mice. The phenotypes seen in dystrophin mutant rats are more representative of the features of human DMD. This implies that rats are better models of human skeletal muscle diseases than mice. In this chapter, we present a detailed protocol for the generation of gene-modified rats by microinjection into embryos using the CRISPR/Cas9 system. Key words CRISPR/Cas9 Genome editing Gene-modified rats Duchenne muscular dystrophy
- Open Access
- 11 November 2022
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 32, 101378
Ketogenic diet containing medium-chain triglyceride ameliorates transcriptome disruption in skeletal muscles of rat models of duchenne muscular dystrophy
- 11 November 2022
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 32, 101378
Open AccessKetogenic diet containing medium-chain triglyceride ameliorates transcriptome disruption in skeletal muscles of rat models of duchenne muscular dystrophy